Financials
| Interim results | Mar. 27, 2024 |
| Half Year Results | Apr. 26, 2023 |
| Full Year Results | Dec. 15, 2022 |
| Half Year Results | Apr. 28, 2022 |
| Full Year Results | Dec. 13, 2021 |
| Interim Results | Apr. 29, 2021 |
| Publication of 2020 Annual Report | Dec. 18, 2020 |
Proxies
| Result of General Meeting | Apr. 15, 2024 |
| Result of AGM | Jan. 23, 2024 |
| Posting of 2023 Annual Report and Notice of AGM | Dec. 18, 2023 |
| Result of AGM | Jan. 24, 2023 |
| Posting of 2022 Annual Report and Notice of AGM | Dec. 19, 2022 |
| Result of AGM | Jan. 18, 2022 |
| Result of AGM | Jan. 19, 2021 |
Ownership Update
| Holding(s) in Company | Apr. 23, 2024 |
| Director/PDMR Share Purchases | Apr. 09, 2024 |
| Holding(s) in Company | Apr. 05, 2024 |
| Holding(s) in Company | Oct. 05, 2023 |
| Holding(s) in Company | Sep. 28, 2023 |
| Holding(s) in Company | Oct. 04, 2022 |
| Holding(s) in Company | Aug. 31, 2022 |
Announcements
| Last day of dealings and update on cancellation | Apr. 25, 2024 |
| Proposed Voluntary Delisting | Mar. 27, 2024 |
| AstraZeneca $11m milestone payment to C4XD | Jan. 03, 2024 |
| Block listing Interim Review | Oct. 02, 2023 |
| Total Voting Rights | Sep. 01, 2023 |
| Exercise of Options, Issue of Equity and TVR | Aug. 18, 2023 |
| Divestment of Orexin-1 to Indivior for £15.95m | Aug. 01, 2023 |